• SPX
  • $5,948.71
  • 0.53 %
  • $31.60
  • DJI
  • $43,870.35
  • 1.06 %
  • $461.88
  • N225
  • $38,283.85
  • 0.68 %
  • $257.68
  • FTSE
  • $8,149.27
  • 0.79 %
  • $64.20
  • IXIC
  • $18,972.42
  • 0.03 %
  • $6.28
Inventiva S.A. (IVA) Stock Price, News & Analysis

Inventiva S.A. (IVA) Stock Price, News & Analysis

Currency in USD Disclaimer

$2.51

-$0.18

(-6.69%)

Day's range
$2.51
Day's range
$2.67
50-day range
$1.53
Day's range
$2.85
  • Country: FR
  • ISIN: US46124U1079
52 wk range
$1.53
Day's range
$4.75


We are preparing, please wait

Analyst Ratings

Key Stats

Key stats represent essential financial metrics and indicators used to evaluate a company's performance and potential investment opportunities.

Stock Score/grades

The Stock Score/Grades evaluate bankruptcy risk and assess the financial strength and fundamental health of a company

  • Altman Z Score -7.88
  • Piotroski Score 3.00
  • Grade Buy
  • Symbol (IVA)
  • Company Inventiva S.A.
  • Price $2.51
  • Changes Percentage (-6.69%)
  • Change -$0.18
  • Day Low $2.51
  • Day High $2.67
  • Year High $4.75

Inventiva S.A., a clinical-stage biopharmaceutical company, focuses on the development of oral small molecule therapies for the treatment of non-alcoholic steatohepatitis (NASH), mucopolysaccharidoses (MPS), and other diseases. Its lead product candidate is Lanifibranor, which has completed Phase IIb clinical trial to treat NASH. The company also develops Odiparcil, which has completed Phase IIa clinical trial for the treatment of MPS VI subtype disease. In addition, it has a pipeline of earlier stage programs in oncology and other diseases. The company has strategic collaboration with AbbVie for the treatment of autoimmune diseases; and Boehringer Ingelheim International GmbH for developing new treatments for idiopathic pulmonary fibrosis. Inventiva S.A. was founded in 2011 and is based in Daix, France.

  • Last Earnings
  • Ex-Dividend for 5/16 Dividend
  • Dividend Payable
  • Today N/A
  • Next Earnings (Estimated) 03/26/2025
  • Fiscal Year End N/A

  • Average Stock Price Target $0.00
  • High Stock Price Target $0.00
  • Low Stock Price Target $0.00
  • Potential Upside/Downside N/A
  • Consensus Rating Sell
  • Rating Score (0-4) N/A
  • Research Coverage N/A

  • EPS (Most Recent Fiscal Year) -$2.64
  • Trailing P/E Ratio -1.34
  • Forward P/E Ratio -1.34
  • P/E Growth -1.34
  • Net Income $-110,426,000

Income Statement

Quarterly

Annual

Latest News of IVA

The Latest News section aggregates recent news posts from various news outlets, offering a comprehensive overview of the most recent developments related to the topic.

Enter your phone number to get Breaking News Updates

Stay ahead with instant updates! Enter your phone number for breaking news alerts, ensuring you're always in the know with the latest developments.


We are preparing, please wait

Inventiva S.A. Frequently Asked Questions

  • What is the Inventiva S.A. stock price today?

    Today's price of Inventiva S.A. is $2.51 — it has decreased by -6.69% in the past 24 hours. Watch Inventiva S.A. stock price performance more closely on the chart.

  • Does Inventiva S.A. release reports?

    Yes, you can track Inventiva S.A.'s financials in yearly and quarterly reports directly on Stocks.News.

  • What is the Inventiva S.A. stock forecast?

    Watch the Inventiva S.A. chart and read a more detailed Inventiva S.A. stock forecast to see what analysts suggest you do with its shares.

  • What is Inventiva S.A. stock ticker?

    The stock ticker can vary on the respective exchange. For instance, on NASDAQ, exchange stock trades by Inventiva S.A. stock ticker.

  • How to buy Inventiva S.A. stocks?

    Like other stocks, IVA shares are sold on stock exchanges such as NASDAQ. The best way to obtain them is through an online stock broker. Open an account, follow the broker's steps, and start trading.

  • What is Inventiva S.A.'s EBITDA?

    Inventiva S.A. measures a company's operating performance, and its growth indicates efficiency improvements. Access more stats in Inventiva S.A.’s financial statements.

  • What is the Inventiva S.A.'s net income ratio for the financial year 2023?

    The net income ratio for the financial year 2023 is -6.3183612748, which equates to approximately -631.84%. This ratio indicates the percentage of net income generated from total revenue and serves as a key measure of a company’s profitability.

  • Should I invest in Inventiva S.A. stocks?

    Investing in stocks requires thorough research. Carefully examine all available data, including Inventiva S.A.'s financials relevant news, and technical analysis. Inventiva S.A.'s technical analysis shows a “buy” rating today and a one-week “buy” rating. Since market conditions can change, it’s wise to look at longer-term trends — the one-month rating for Inventiva S.A. stock currently indicates a “sell” signal. For more insights, review Inventiva S.A.’s technical analysis.

  • A revenue figure for Inventiva S.A. for its last quarter?

    Inventiva S.A. published it's last quarterly revenues at $2.73 M.

Portfolio Sync Solutions

Streamline your investment strategy with our portfolio synchronization tools. Seamlessly manage and track your holdings across platforms for enhanced

GET STARTED
Portfolio Sync Solutions
×
New Alert

Select an alert type

Choose sentiment spike or mentions spike or both to receive email alerts and app notification for the selected stock.
Note: Please be aware that you will receive an email only once a day, around 8:00 AM (EST), in the event of any spike.
In future if you don't want to receive any email then delete stocks added into alert section.

New Alert

Setup alert

×

Premium Content

This content is only available for premium members. Please become a paid member to access.

Download App

Currently, memberships can only be purchased through the app.

×

Log In


or

download app using google store Continue with Google download app using apple Continue with Apple

Email Verification

An email with a verification code has been sent to your email address.

Welcome to Stocks.News!

Create Your Account

Email Verification

An email with a verification code has been sent to your email address.